Drug Profile
RWJ 50515 035
Alternative Names: RWJ 50515035Latest Information Update: 12 Jun 2001
Price :
$50
*
At a glance
- Originator Johnson & Johnson Pharmaceutical Research & Development
- Developer Johnson & Johnson Pharmaceutical Research & Development LLC
- Class Analgesics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 12 Jun 2001 No-Development-Reported for Pain in USA (Unknown route)
- 09 Jun 1997 New profile
- 09 Jun 1997 Preclinical development for Pain in USA (Unknown route)